Cambridge Healthtech Institute’s 3rd Annual

NK Cell-Based Cancer Immunotherapy
( NK细胞基础的癌症免疫疗法 )

2018年9月26日~27日

A growing number of studies into pathways elucidating NK cell biology, activating and suppressing NK cell function, the development of pharmacological and genetic methods to enhance NK cell anti-tumor immunity, and the ability to expand NK cells ex vivo have set the stage for a new generation of cancer immunotherapies. As preclinical and clinical studies continue, there is a clear need to better understand the mechanisms underlying the regulation of NK cell phenotype and function within the tumor environment to accelerate the development of NK cell-targeting therapeutics.

 

Cambridge Healthtech Institute’s 3rd Annual NK Cell-Based Cancer Immunotherapy conference will once again convene immuno-oncology researchers, cancer immunotherapy developers, and technology providers to discuss current challenges and opportunities - from discovery NK immuno-oncology to clinical studies, share latest technologies and development approaches, as well as to provide updates on preclinical, clinical, and combination studies.

 

Who should attend: Executives, Directors, Managers, Researchers, and Scientists from pharma, biotechs, academia, government and healthcare organizations working in fields such as oncology, immunology, drug discovery, molecular/cell biology, biochemistry, chemical biology, structural biology and medicinal chemistry

 

Coverage will include, but is not limited to:                                        

  • Biology of tumor microenvironment and immune NK pathways
  • Mechanisms underlying regulation of NK cell phenotype and function within the tumor environment
  • Novel and emerging tumor antigens for targeting
  • Cancer immunotherapy strategies
  • Development of monoclonal antibodies to activate of suppress NK cell function
  • Adoptive NK cell-based therapies such as chimeric antigen receptors (CAR-NK)
  • Combination strategies
  • Updates on preclinical and clinical studies
  • Novel approaches to enhance the number and function of NK cells
  • Technological Innovations for NK cell expansion and engineering

 

* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English





免费电子邮件通知服务